{"issuance_frequency":"","notes_translated":{"fr":"Le présent avis de biosécurité est émis par l’Agence de la santé publique du Canada (ASPC) en vue d’aider les laboratoires cliniques ainsi que ceux de diagnostic et de recherche à mettre en œuvre des procédures de biosécurité appropriées où sont manipulés des échantillons pouvant contenir le SARS-CoV-2.","en":"This biosafety advisory is being provided by the Public Health Agency of Canada (PHAC) to assist clinical, diagnostic, and research laboratories in implementing proper biosafety procedures to handle samples that may contain SARS-CoV-2."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"b1a11728-df1d-4774-8221-f84581c8a882","metadata_created":"2020-05-08T18:50:40.847375","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-05-08T18:50:40.847383","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-05-08","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["SARS-CoV-2","avis de biosécurité","laboratoires cliniques","de disagnostic et de recherche"],"en":["SARS-CoV-2","Biosafety advisory","clinical","diagnostic","and research laboratories."]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2 pour Coronavirus du syndrome respiratoire aigu sévère 2)","en":"SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2)"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"b1a11728-df1d-4774-8221-f84581c8a882","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"75ab02d4-ac20-4ddc-88e7-662dff6457fb","related_relationship":"","name_translated":{"fr":"SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2 pour Coronavirus du syndrome respiratoire aigu sévère 2)","en":"SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2)","language":["en"],"created":"2020-05-08T18:50:41.028818","url":"https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/biosafety-directives-advisories-notifications/novel-coronavirus-january-27.html","last_modified":null,"position":0,"revision_id":"432388a2-857c-4466-97b4-1dee4db08273","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"b1a11728-df1d-4774-8221-f84581c8a882","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e4d3bace-27f7-47d3-a084-95a03c0f4c98","related_relationship":"","name_translated":{"fr":"SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2 pour Coronavirus du syndrome respiratoire aigu sévère 2)","en":"SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2)"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2)","language":["fr"],"created":"2020-05-08T18:50:41.028826","url":"https://www.canada.ca/fr/sante-publique/services/biosecurite-biosurete-laboratoire/directives-avis-avis-speciaux-matiere-biosecurite/nouveau-coronavirus-27-janvier.html","last_modified":null,"position":1,"revision_id":"432388a2-857c-4466-97b4-1dee4db08273","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2020-02-29 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"b1a11728-df1d-4774-8221-f84581c8a882","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This biosafety advisory is being provided by the Public Health Agency of Canada (PHAC) to assist clinical, diagnostic, and research laboratories in implementing proper biosafety procedures to handle samples that may contain SARS-CoV-2.","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2)","revision_id":"432388a2-857c-4466-97b4-1dee4db08273"}